Loading...
Encompass Health Corporation
EHC•NYSE
HealthcareMedical - Care Facilities
$121.61
$0.32(0.26%)
Encompass Health Corporation (EHC) Financial Performance & Statements
Review Encompass Health Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
11.91%
↑ 11.91%
Operating Income Growth
18.13%
↑ 18.13%
Net Income Growth
29.46%
↑ 29.46%
Operating Cash Flow Growth
-100.36%
↓ 100.36%
Operating Margin
16.76%
↑ 16.76%
Gross Margin
36.45%
↑ 36.45%
Net Profit Margin
8.97%
↑ 8.97%
ROE
24.66%
↑ 24.66%
ROIC
15.97%
↑ 15.97%
Encompass Health Corporation (EHC) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Encompass Health Corporation stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.46B | $1.41B | $1.35B | $1.30B |
| Cost of Revenue | $762.30M | $756.80M | $948.90M | $1.04B |
| Gross Profit | $693.10M | $648.20M | $402.10M | $266.10M |
| Gross Profit Ratio | $0.48 | $0.46 | $0.30 | $0.20 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $52.30M | $69.20M | $54.00M | $50.50M |
| Operating Expenses | $426.10M | $415.90M | $54.00M | $50.50M |
| Total Costs & Expenses | $1.19B | $1.17B | $1.14B | $1.09B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $31.80M | $33.00M | $34.90M | $34.30M |
| Depreciation & Amortization | $79.20M | $78.00M | $78.40M | $72.90M |
| EBITDA | $304.10M | $312.40M | $297.10M | $288.50M |
| EBITDA Ratio | $0.21 | $0.22 | $0.22 | $0.22 |
| Operating Income | $197.00M | $232.30M | $209.10M | $215.60M |
| Operating Income Ratio | $0.14 | $0.17 | $0.15 | $0.17 |
| Other Income/Expenses (Net) | $41.60M | -$30.90M | -$25.30M | $38.30M |
| Income Before Tax | $238.60M | $201.40M | $183.80M | $186.00M |
| Income Before Tax Ratio | $0.16 | $0.14 | $0.14 | $0.14 |
| Income Tax Expense | $41.60M | $37.60M | $36.00M | $38.30M |
| Net Income | $151.50M | $120.90M | $108.20M | $114.10M |
| Net Income Ratio | $0.10 | $0.09 | $0.08 | $0.09 |
| EPS | $1.50 | $1.20 | $1.08 | $1.13 |
| Diluted EPS | $1.48 | $1.18 | $1.06 | $1.12 |
| Weighted Avg Shares Outstanding | $100.50M | $100.00M | $99.90M | $99.90M |
| Weighted Avg Shares Outstanding (Diluted) | $102.10M | $102.30M | $102.10M | $102.00M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan